Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 NIH consensus conference. Intravenous immunoglobulin. Prevention and treatment of disease.

× No keyword cloud information.

19 in total

Review 1. Adverse effects of intravenous immunoglobulin therapy.

Authors: U E Nydegger; M Sturzenegger
Journal: Drug Saf Date: 1999-09 Impact factor: 5.606

2. Subcutaneous immunoglobulin in lymphoproliferative disorders and rituximab-related secondary hypogammaglobulinemia: a single-center experience in 61 patients.

Authors: Nicolò Compagno; Francesco Cinetto; Gianpietro Semenzato; Carlo Agostini
Journal: Haematologica Date: 2014-03-28 Impact factor: 9.941

Review 3. Intravenous immunoglobulin: adverse effects and safe administration.

Authors: Hedi Orbach; Uriel Katz; Yaniv Sherer; Yehuda Shoenfeld
Journal: Clin Rev Allergy Immunol Date: 2005-12 Impact factor: 8.667

Review 4. Basic principles of intravenous immunoglobulin (IVIg) treatment.

Authors: Martin Stangel; Refik Pul
Journal: J Neurol Date: 2006-09 Impact factor: 4.849

Review 5. Intravenous immunoglobulin therapy for acquired coagulation inhibitors: a critical review.

Authors: Koji Yamamoto; Junki Takamatsu; Hidehiko Saito
Journal: Int J Hematol Date: 2007-05 Impact factor: 2.490

6. Dosing and therapy utilization: a discussion of updates on PI treatment guidelines.

Authors: Mark Ballow
Journal: J Clin Immunol Date: 2012-06-23 Impact factor: 8.317

Review 7. Criteria for the appropriate drug utilisation of immunoglobulin.

Authors: P Thürmann; S Harder
Journal: Pharmacoeconomics Date: 1996-05 Impact factor: 4.981

Review 8. Immunthrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity.

Authors: P Imbach; J Akatsuka; V Blanchette; A Burek-Kozlowska; J Bussel; G Gaedicke; A Gianella-Borradori; E Gugler; A Hirt; B Imholz
Journal: Eur J Pediatr Date: 1995 Impact factor: 3.183

Review 9. Common variable immunodeficiency: clinical aspects and recent progress in identifying the immunological defect(s).

Authors: M M Eibl; H M Wolf
Journal: Folia Microbiol (Praha) Date: 1995 Impact factor: 2.099

Review 10. Intravenous immunoglobulin for myasthenia gravis.

Authors: Philippe Gajdos; Sylvie Chevret; Klaus V Toyka
Journal: Cochrane Database Syst Rev Date: 2012-12-12